Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Beta Bionics, Inc. (BBNX) had Free Cash Flow per Share of $-0.82 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$23.24M |
|
$-16.87M |
|
$10.73M |
|
$12.50M |
|
$43.11M |
|
$-19.87M |
|
$3.00M |
|
$-16.87M |
|
$-16.87M |
|
$-16.87M |
|
$-16.87M |
|
$-16.87M |
|
$-16.87M |
|
$-19.87M |
|
$-19.22M |
|
43.39M |
|
43.39M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$286.07M |
|
$6.46M |
|
$43.90M |
|
$329.97M |
|
$19.49M |
|
-- |
|
$8.85M |
|
$28.34M |
|
$301.63M |
|
$301.63M |
|
$301.63M |
|
43.47M |
|
| Cash Flow Statement Financials | |
$-33.57M |
|
$-172.95M |
|
$211.16M |
|
$30.53M |
|
$35.17M |
|
$4.64M |
|
$7.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
53.80% |
|
-85.52% |
|
-85.52% |
|
-- |
|
-72.59% |
|
-72.59% |
|
$-35.68M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.62 |
|
2.04 |
|
44.13 |
|
-5.59% |
|
-5.59% |
|
-5.11% |
|
-5.59% |
|
$6.94 |
|
|
Free Cash Flow per Share |
$-0.82 |
$-0.77 |
|